Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy

Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy

US Patent 6232299 · Granted May 15, 2001

Estimated economic value: $406,429,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solubilized compositions for controlled proliferation of stem cells / generating2022
Co-therapy comprising canagliflozin and phentermine for the treatment of obesity2021
Thermoreversible compositions for administration of therapeutic agents2021
Solubilized compositions for controlled proliferation of stem cells / generating2021
Fatty acid cysteamine conjugates and their use as activators of autophagy2019
Thermoreversible compositions for administration of therapeutic agents2019
Solubilized compositions for controlled proliferation of stem cells / generating2019
Solubilized compositions for controlled proliferation of stem cells / generating2018
Fatty acid niacin conjugates and their uses2017
Fatty acid niacin conjugates and their uses2017
Fatty acid acylated salicylates and their uses2017
Niacin conjugated fatty acid mixtures and their uses2016